Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Targovax ASA: Third quarter 2017 results

Oslo, Norway, 2 November 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces its third quarter 2017 results. A meeting for investors, analysts and press will take place in Oslo today at 10:00 CET (details below). HIGHLIGHTS FOR THE THIRD QUARTER 2017 Research & Development · Targovax presented data from three trials at the annual meeting of the European Society of Molecular Oncology (ESMO) in September in Madrid, highlighting some of the important clinical progress from both of its

Asetek Announces OEM Partnership with E4 Computer Engineering and Installation

November 2, 2017 – Asetek® (ASETEK.OL) today announced E4 Computer Engineering, an Italian technology provider of solutions for HPC, data analytics and AI, as a new data center OEM partner. E4 Computer Engineering has utilized Asetek RackCDU D2C™ (Direct-to-Chip) liquid cooling for the D.A.V.I.D.E. SUPERCOMPUTER in Italy. This follows the announcement  of an undisclosed OEM partner and installation on July 14, 2017. You can read more about the partnership at Asetek.com 

Dignitana decides on a Rights Issue of 42.6 MSEK

The Board of Directors of Dignitana AB ("Dignitana" or "The Company") has decided on a new share issue of 42.6 MSEK with preferential rights for existing shareholders (the "Issue"). The Issue decision requires approval at the Extraordinary General Meeting on December 4, 2017. Invitation to the General Meeting is published by a separate press release. The Rights Issue is secured through agreements on subscription and guarantee commitments to MSEK 34.3, corresponding to approximately 81 percent of the issue allowance.Summary · The Board of Directors of Dignitana has decided on a

Multiconsult ASA – Repurchase of own shares

On 1 November 2017, Multiconsult ASA ("Multiconsult") purchased 2 865 of its own shares at an average price of NOK 86.21 per share. The shares were purchased in accordance with the Company's share repurchase programme as announced on 22 September 2017. The shares were acquired on Oslo Børs.Following this transaction Multiconsult holds 106 742 of its own shares.  For further information, please contact: Investor relations:       Mirza Koristovic, Head of Investor Relations       Phone: +47 93 87 05 25       E-mail: ir@multiconsult.no Media:       Gaute Christensen, VP

Camurus announces that FDA advisory committee recommends approval of CAM2038 for treatment of opioid use disorder

Lund, Sweden — 1 November 2017 — Camurus (NASDAQ STO: CAMX) today announced that the US Food and Drug Administration’s (FDA) Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee jointly voted 17-3 recommending approval of CAM2038, an investigational buprenorphine weekly and monthly depot injection for the treatment of adults with opioid use disorder (OUD). “The Advisory Committee’s recommendation for approval of CAM2038 represents a significant step towards making CAM2038 available to patients in the US,” said Fredrik Tiberg, President

Cherry revises its full-year forecast for 2017 and presents preliminary earnings summary for the third quarter

Cherry AB (publ) – STO: CHER-B.ST – has, prior to the release of its third quarter report, performed a more detailed analysis of development in its subsidiary ComeOn! Consequently, the Cherry Group is revising its full-year forecast for 2017, from revenue generated of approximately MSEK 2,500 to about MSEK 2,200, and profit (EBITDA) from about MSEK 480 to about MSEK 400.The process of integrating ComeOn! has not been implemented according to plan, and the delay that occurred during the summer, combined with erroneous marketing decisions, contributed to higher costs and a weaker earnings

Triton to sell Infratek Group to VINCI Group, a global player in concession and constructing

· Since Triton's acquisition, Infratek Group has become the leading total supplier in the Nordic region within building, operating and maintaining critical infrastructure · VINCI Group`s and Infratek Group's operations are complementary and the combined business is expected to further enhance customer and consumer offerings in the Nordics · The parties have agreed not to disclose the terms of the transaction. The sale is subject to regulatory approval. Oslo, Norway, 1 November 2017 - Funds advised by Triton ("Triton") today announced the sale of the Infratek Group ("Infratek"), a

Report from the Extraordinary General Meeting of Alimak Group AB held on 1 November 2017

Alimak Group AB held its Extraordinary General Meeting on Wednesday 1 November 2017. The main resolutions passed at the meeting were as follows. More detailed information about the contents of the resolutions may be obtained from the complete notice of the Extraordinary General Meeting and the complete proposals. The notice and complete proposals are available on the company’s website, www.alimakgroup.com  Election of a new director and information on the resigning director Since Triton has sold its shares to Latour, Carl Johan Falkenberg leaves his Board position in connection

Johan Björkenheim to join Metsäliitto Cooperative’s Board of Directors

At a meeting held on 1 November 2017, the Supervisory Board of Metsä Group’s parent company, Metsäliitto Cooperative, elected forestry and agriculture entrepreneur Johan Björkenheim to be a new member of Metsäliitto Cooperative’s Board of Directors as of 1 January 2018. Björkenheim has a long time experience from forestry as well as from positions of trust in Metsäliitto Cooperative. He has been a member of the Representative Council during the years 1999–2011 and a member of the Supervisory Board as from 2011.Metsä Group Stock Exhange release 1 November 2017 at 6.30 pm EET At a meeting

Major League Baseball Players Alumni Association Brings Legends for Youth Baseball Clinic Series to Nicaragua

Free youth baseball clinic to feature Charles Gipson, Desi Relaford and other MLB AlumniColorado Springs, Colo. – Nicaraguan youth will have an opportunity to play with their big league heroes at the Major League Baseball Players Alumni Association (MLBPAA) Legends for Youth baseball clinic series. In conjunction with Rancho Santana, the free clinics will feature* MLB veterans Porfi Altamirano, Marvin Benard, Charles Gipson, Oreste Marrero and Desi Relaford, who will teach baseball skills, drills and life lessons for approximately 200 local youth. These five players combine for 33 seasons,

Cxense ASA: Sale of all shares in Mporium Group plc

Reference is made to the stock exchange notice made by Cxense ASA (“Cxense” or the “Company”) on 24 August 2017 regarding the new board and management’s decision to pursue a growth strategy with focus on DMP with Intelligent Personalization and to divest non-core business. In line with this new strategy, the Company has today, on 1 November 2017, entered into agreements for sale of all its 113,123,403 shares in Mporium Group plc (“Mporium”), representing approximately 21.16% of the voting rights in Mporium, for net proceeds of GBP 2.83 million (USD 3.75 million). After this transaction

Total Voting Rights

01 November 2017 15:00 GMT Transparency Directive Voting Rights and Capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 October 2017 the issued share capital of AstraZeneca PLC with voting rights is 1,265,948,818 ordinary shares of US$0.25. No shares are held in Treasury. Therefore, the total number of voting rights in AstraZeneca PLC is 1,265,948,818. The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which

Changes in the nomination committee’s proposal for election of board members in AcadeMedia

Changes in the nomination committee’s proposal for election of board members in AcadeMedia Due to the fact that EQT, after its sale of shares on 26 October 2017, no longer owns any shares in AcadeMedia, Erika Henriksson has informed the nomination committee that she declines re-election at the annual general meeting on 24 November 2017. The nomination committee therefore proposes that Anki Bystedt instead is elected new member of the board. There are no other changes in the nomination committee’s proposal for AcadeMedia’s annual general meeting, which was published in the notice on 24

Vitec Software Group AB: Notice of Extraordinary General Meeting

Extraordinary general meeting of Vitec Software Group AB (publ) decided November 1, 2017 to issue a convertible bond for employees in Vitec. Summary of decision; · The convertible bond is maximized to 2,500 debentures each at SEK 10,000. · The conversion rate is set at 120 % of the average market price of Vitec's share (B share) during the period 2-17 November 2017. · At full conversion, the number of shares is expected to increase by approximately 260,000. This corresponds to an increase in the share capital by SEK 26,000 and a dilution of approximately 0.9% of the share

MPI and OV announces registration of trademark for DRP

Hoersholm, Denmark – November 1st 2017 – Oncology Venture Sweden AB:s (OV:ST) and Medical Prognosis Institute A/S (MPI.ST) today informed that the United States Patent & Trademark Office (USTPO) has allowed and registered its primary trademark, DRP®, used in connection with the Company’s core predictive biomarker platform and services. The DRP® biomarker platform uses tumor mRNA and proprietary analytics to develop tumor-derived genetic signatures, which are used to identify which cancer patients are likely to respond to a given anti-cancer drug. This proprietary technology has been

Mandatory notification of trade

On November 1, 2017, Chairman of the Board in Atea ASA, Ib Kunøe acquired 9,116 shares of Atea ASA at an average price of NOK 102,52.Following the transaction, Ib Kunøe and close associates hold 27,015,326 shares in Atea ASA, representing 25.1% of the share capital.  For further information, please contact:Robert Giori, CFO Atea ASA, mobile +47 934 09 188Ole Johan Fjellestad, Group Chief Accountant, mobile +47 992 74 829 About Atea Atea is the leading supplier of IT infrastructure and system integration in the Nordic and Baltic regions with 6,900 employees. Atea is present

#17-1030 Listing of instrument issued by UBS AG

As from November 03, 2017, 1 instrument issued by UBS AG will be listed on NDX Miscellaneous Investment Products Sweden. The instrument will be registered at Euroclear Sweden AB.Issuer: UBS AG Agent: Exceed For more details see attached file. For further information concerning this NDX notice please contact: NDX Listing on +46 8 566 390 20 or at ndxlist@ngm.se Nordic Growth Market NGM AB About NDX Nordic derivatives Exchange (NDX) is a market for listing and trading of derivatives and other structured products. The market is operated by Nordic Growth Market (www.ngm.se),

#17-1029 Listing of instrument issued by Skandinaviska Enskilda Banken AB

As from November 02, 2017, 1 instrument issued by Skandinaviska Enskilda Banken AB will be listed on NDX Miscellaneous Investment Products Sweden. The instrument will be registered at Euroclear Sweden AB.Issuer: Skandinaviska Enskilda Banken AB Agent: SEB For more details see attached file. For further information concerning this NDX notice please contact: NDX Listing on +46 8 566 390 20 or at ndxlist@ngm.se Nordic Growth Market NGM AB About NDX Nordic derivatives Exchange (NDX) is a market for listing and trading of derivatives and other structured products. The market

Camden Making Strides in War on Food Waste

Innovative new app is tackling food waste in CamdenIf food waste was a country, it would be the third largest emitter of greenhouse gases after the US and China. This shocking statistic should be enough for anyone to realise that food waste is a problem we need to act on, and it is something anyone can play a part in. Tackling food waste is especially important in London, where it costs the average person £200 a year. As well as this, for every 5 bags of shopping bought, one is thrown away with food that could have been used to feed hungry mouths. Reducing food waste has benefits for

Cantargia announces a new date for the third quarter interim report

Cantargia AB (“Cantargia”) today announces that the interim report for the third quarter 2017 will be published earlier than previously planned. The new date is November 8 2017, while the previously communicated date was November 15, 2017.For further information, please contact  Göran Forsberg, CEOTelephone: +46 (0)46-275 62 60E-mail: goran.forsberg@cantargia.com This constitutes information that Cantargia is required to publish under the EU’s Market Abuse Regulation. The information was submitted for publication through the above contact person on 1 November 2017, at 15.00 CET.

Coor completes divestment of Damage Services operations in Norway

On 26 September 2017, Coor announced that it had signed an agreement with Polygon, the European market leader in property damage control, regarding the sale of the Damage Service operations in Norway. The divestment has now been approved by the Norwegian competition authority following the usual validation process. This means that the divestment has been completed as of today’s date, 1 November 2017.For more information, please contact: Olof StålnackeCFO and IR Manager, Coor+46 10 559 59 20olof.stalnacke@coor.com  Sofie SchoughActing Communication Director, Coor+4610 559 59

Nuevolution AB (publ) announces timing for the release and webcast of the three-month report for July-September 2017

Stockholm, 1 November 2017 – Nuevolution AB (publ) (NUE.ST) announces today that it will report its report for the three-month period 1 July - 30 September 2017 on Tuesday 7 November at 8:30 CET. On Tuesday 7 November at 14:00 CET, the company’s executive management will host a conference call and webcast discussion of the results and provide an update on the pipeline programs and partnering activities. Access to the event can be obtained as follows: LIVE access on Tuesday 7 November at 14:00 CET Telephone numbers: SE: +46 85 664 2690 DK: +45 3544 5576 UK: +44 20 3008 9804

Senior managers buy shares in NOTE

In February 2017, within the framework of an incentive program, NOTE's largest shareholder Creades AB issued a total of 577 453 call options to senior managers in NOTE. Each call option gave the holder the right to purchase a share in NOTE at a price of SEK 17.58 in cash during the period 25 October–8 November 2017. The options were priced on market terms and the program does not imply any dilution of other owners' NOTE shareholdings.All participants have now bought shares and called for redemption of the remaining options. In total, the participants purchased 196,000 shares, which means

Outokumpu – Manager transaction: Markus Akermann

Outokumpu OyjStock exchange releaseNovember 1, 2017 at 4.00 pm EET Outokumpu has received a notification from Markus Akermann, member of the Board of Directors, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given in the table below.  Name of the manager Markus AkermannPosition in the issuer Member of the Board of DirectorsIssuer Outokumpu OyjIssuer’s LEI reference 5493009YRUJJDCFF0R80Notification type Initial

There are no items matching the current filter
There are no more items matching the current filter
Back to top